“The ideal situation is to have an enabling environment for pharmaceutical manufacturing and for that to happen we need to put a few things in place, first is manufacturing infrastructure and second is expertise”.

Prof. Chimezie Anyakora (CEO, Bloom Public Health; Interviewed 2020)